# European Institute of Oncology

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/european-institute-of-oncology/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 82.4 |
| Citations | 3,426,513 |
| City | Milan |
| Country | IT |
| Description | European Institute of Oncology is a research organisation in Milan, IT. OpenAlex records 22,589 works and 3,426,513 citations for it. 3,310 researchers list it as their most recent affiliation. |
| Homepage | https://www.ieo.it/en/ |
| OpenAlex ID | https://openalex.org/I6141010 |
| Researchers | 3,310 |
| ROR ID | https://ror.org/02vr0ne26 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q1376693 |
| Works | 22,589 |

## University collaborators

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [Christian-Albrechts-Universität zu Kiel](https://scholariq.org/institutions/christian-albrechts-universitat-zu-kiel/)

## University papers

Showing 12 of 40.

- [Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/maintenance-olaparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer](https://scholariq.org/papers/olaparib-plus-bevacizumab-as-first-line-maintenance-in-ovarian-cancer/)
- [ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma](https://scholariq.org/papers/esgo-estro-esp-guidelines-for-the-management-of-patients-with-endometrial/)
- [ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up](https://scholariq.org/papers/esmo-esgo-estro-consensus-conference-on-endometrial-cancer-diagnosis-treatment/)
- [Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis](https://scholariq.org/papers/alcohol-consumption-and-site-specific-cancer-risk-a-comprehensive-dose-response/)
- [Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial](https://scholariq.org/papers/paclitaxel-plus-platinum-based-chemotherapy-versus-conventional-platinum-based/)
- [Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/newly-diagnosed-and-relapsed-epithelial-ovarian-carcinoma-esmo-clinical-practice/)
- [Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer](https://scholariq.org/papers/pembrolizumab-for-persistent-recurrent-or-metastatic-cervical-cancer/)
- [Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis](https://scholariq.org/papers/cancer-immunotherapy-efficacy-and-patients-sex-a-systematic-review-and-meta/)
- [Cancer and fertility preservation: international recommendations from an expert meeting](https://scholariq.org/papers/cancer-and-fertility-preservation-international-recommendations-from-an-expert/)
- [Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women](https://scholariq.org/papers/prevention-of-breast-cancer-with-tamoxifen-preliminary-findings-from-the-italian/)
- [ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer](https://scholariq.org/papers/esmo-esgo-estro-consensus-conference-on-endometrial-cancer/)

## University researchers

- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.